遺伝子検査のジェネシスヘルスケア株式会社

Genesis Healthcare Co., Ltd., Pioneer of Genetic Test Service,
Raises 1.65 Billion Yen Newly

FEBRUARY 27, 2018
Genesis Healthcare Co.

Genesis Healthcare Co.,Ltd. (Dr. Iri Sato Baran Co-founder and President) Japan’s pioneer genetic testing and research company, has completed a third-party equity allocation to Rakuten, Inc. (TSE: 4755) (Hiroshi Mikitani, Representative Director, Chairman, President and CEO) hereinafter referred to as “Rakuten” and Omron Healthcare Co., Ltd. (Isao Ogino, President and CEO) hereinafter referred to as “Omron Healthcare”. Genesis’ Capital has increased to 3.78B Yen, and Genesis’ post-money valuation is approximately 42 billion yen.

As the market leader of genetic testing and research field in Japan, Genesis Healthcare has actively pursued to develop the Japanese scientific landscape through numerous R&D, product development, raising awareness via human resource development and advanced education and translating genetic data into useful solutions. As of today, Japanese genetic platform exceeds 550,000, the largest in Japan and potentially in Asia. In 2018, we aim to accumulate data of 1 million people, or 1% of the population in Japan.

This will be Rakuten’s second investment since its initial investment in August 2017. Rakuten commitment to assist in the development and advancement of genetic technology and its useful applications in the healthcare is a novel approach to fostering innovation.  

Secondly, Omron Healthcare and Genesis has formed a partnership since 2014. Both companies jointly developed a personalized health solution business model combining genetic test kit from Genesis and digital health wearables from Omron Healthcare. The new capital will further strengthen the partnership as the addition of biometric information such as blood pressure from Omron’s precision wearable devices will maximize the utility of Genesis genetic data sharing platform. By analyzing various datas, both Omron Healthcare and Genesis will develop and provide services to predict future in advance in advance illness,
treatment to prevent the onset of the disease, and guidance on health management. Together, we will work together to promote and realize the ideal solution for personalized healthcare.
The equity value is based on the latest financing stock price of Omron Healthcare Co., Ltd. multiplied by the total number of issued stocks
As a leading company in genetic field in Japan, we will continue to pursue the development of genetic research and tests in Japan and then explore the markets in worldwide.

About Genesis Healthcare Co. Ltd

Since the founding of Genesis Healthcare Co., Ltd in 2004, we have grown our business to offer a full array of Genetic Research and Testing Services, ranging from Consumer-based-testing, diagnostic testing and gene therapy (AAV) As one of the oldest research and genetic testing companies in Japan, we have earned a solid reputation through our long experience and technological abilities.  

About Rakuten

Rakuten, Inc. (TSE: 4755) is a global leader in internet services that empower individuals, communities, businesses and society. Founded in Tokyo in 1997 as an online marketplace, Rakuten has expanded to offer services in e-commerce, fintech, digital content and communications to more than 1 billion members around the world. Since 2012, Rakuten has ranked in the top 30 of Forbes Magazine's annual "World's Most Innovative Companies" list. The Rakuten Group has over 14,000 employees, and operations in 29 countries and regions. For more information visit https://global.rakuten.com/corp/.

About Omron Healthcare

Committed to improving people's lives, Omron Healthcare provides clinically proven, innovative medical equipment for health monitoring and therapy. Our product portfolio includes blood pressure monitors, nebulizer, electronic thermometers, blood glucose monitors and activity counters as well as body composition monitors and professional medical devices. For many decades, Omron's devices have helped people to prevent, treat and manage lifestyle diseases both at home and in clinical practice in more than 100 countries in the world. Omron Healthcare Group is headquartered in Muko City, Kyoto Prefecture, Japan. Its President is Isao Ogino.
For more information visit https://www.healthcare.omron.co.jp/



Genesis Healthcare Co.
Corporate site: www.genesis-healthcare.jp
Press Inquiries:Public Relations Division
TEL:+81-3-5422-8506 
Attention; Public Relations Div
E-mail: infogene@genelife.jp

Copyright © GENESIS HEALTHCARE CO. All Rights Reserved.

up